The use of so-called "mix and match" COVID-19 vaccine boosters may give a stronger immune response than sticking to one type of jab, the EU's drug watchdog said on Thursday.
Oct 21, 2021
0
3
A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.
Oct 21, 2021
0
2
U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when—and whether using a competing brand for the second dose might provide better protection.
Oct 15, 2021
0
2
People who received Johnson & Johnson's COVID-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
Oct 14, 2021
0
29
COVID-19 vaccine choices are getting more complicated. So don't feel bad if you are confused about the different COVID-19 vaccines and who's eligible for what. In addition to the three original vaccines approved by the Food ...
Oct 8, 2021
0
41
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in youngsters and help schools ...
Oct 7, 2021
0
2
The European Union's drug regulator gave its backing Monday to administering booster shots of the Pfizer-BioNTech COVID-19 vaccine for people 18 and older.
Oct 4, 2021
0
0
Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.
Sep 29, 2021
0
40
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
(HealthDay)—Pfizer plans to request approval for use of its COVID-19 vaccine in children under 12 soon.
Sep 27, 2021
0
5
